Navigation Links
Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study

atements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details and a discussion of risks and uncertainties that may impact forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A, "Risk Factors" in the company's first quarter 2007 10-Q.

Media Contacts:
Mary-Fran Faraji
908)-247-6959 - mobile
Catherine Cantone
(908) 298-3944
(908) 327-3013 mobile

Investor Contact:
Alex Kelly
(908) 298-7436


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
2. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
3. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
6. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
9. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
10. Alzheimers Drug Shows Promise in Fighting Cancer
11. Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease
Post Your Comments:
(Date:8/18/2008)... BETHESDA, Md., Aug. 18 /...ical company developing novel, proprietary,antibod...autoimmune,diseases, will host a webcast and confe...at 10:00 a.m. Eastern Time (4:00 p.m. Central Euro...ere published in the Journal,SCIENCE on August 15,...
(Date:8/14/2008)... PRINCETON, N.J., Aug. 14 /PRNewswire-FirstCall/...stage pharmaceutical company committed to,discover... treat viral,infections, reported unaudited financ...e 30, 2008. Pharmasset reported a net loss attribu...a loss per share of $0.69 for the,quarter ended Ju...
(Date:8/13/2008)... Provides risk managers with comprehensive overvi...posure and required coverage, CHICAGO, Aug. 13 /P...,technology arm of Aon Corporation (NYSE: AOC ) a...ce solutions, today announced it has launched a ne...he market-leading,browser-based risk management i...
(Date:8/13/2008)... Reduction of CRP with ISIS 353512 could provide ...renal and inflammatory diseases, CARLSBAD, Calif....ticals, Inc. (Nasdaq: ISIS ) announced today it h...tisense drug that inhibits the,production of C-rea...vated,in patients with a variety of diseases inclu...
Breaking Medicine Technology:Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 1WuXi PharmaTech 28NYSE 3A WX 29 Promotes Edward Hu to COO 2442 2Pharmos Corporation Announces Board and Management Changes 2440 1Pharmos Corporation Announces Board and Management Changes 2440 2Pharmos Corporation Announces Board and Management Changes 2440 3Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 1Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 2Biodel Inc Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject 28TM 29 and Plans Manufacturing Facility for VIAject 28TM 29 1136 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 1Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 2Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 3Takeda Submits New Drug Application for Alogliptin 28SYR 322 29 in the U S 1134 4
...ss.--(BUSINESS WIRE)--Mar 14, 2007 - ArQule, Inc.,...ociety of,Clinical Oncology (ASCO) has accepted fo... 197 (A Phase 1 Dose Escalation Study of,ARQ 197, ...ients,with Metastatic Solid Tumors) at the 43rd AS...s presentation will describe findings,from a Phase...
...lough Announces Presentation Of Phase II Trial Res...t The 2007 Annual,Meeting Of The American College ...6, 2007 /PRNewswire-FirstCall/ --,Schering-Plough ...ase II trial of its novel oral thrombin receptor a...e 2007 annual Scientific Sessions,of the of Cardio...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Media Advisory: ACC Updated Schedule 2
(Date:8/20/2008)...usetts General Hospital (MGH) investigators have f...em cell appeared to protect gastrointestinal tissu...ir report published in the journal Stem Cells , t...icine report that mesenchymal stem cells (MSCs), k...allowed the regeneration of the gastrointestinal l...
(Date:8/20/2008)...NGTON, Aug. 20 /PRNewswire-USNewswire/ -- Yesterda... admitted to Huron Hospital after,suffering an ane...Ohio. At,the present time Rep. Tubbs Jones, condit...are available., Tuesday,s condition followed a fu...ming forum on electoral reform, scheduled for Sept...
(Date:8/20/2008)... Micro(R) PUMP and ELLEgirl.com Send Four Girls to...Summer, LOS ANGELES, Aug. 20 /PRNewswire/ -- Reti...eenage Web site ELLEgirl.com to send four contest,...Camp in Santa Monica,California. With the new sch...mpower girls to become successful women by helping...
(Date:8/20/2008)...IEGO, Aug. 20 /PRNewswire/ --You,re late for work,...r car won,t start. How do you deal with,the rising...ash out in,frustration, how you deal with anger af...r children and even your career., As hard as we m...push,our buttons. While feeling anger isn,t a bad ...
Breaking Medicine News(10 mins):Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5Health News:Taming Your Temper: Learning to Turn Down the Heat 2
...MA today criticises a recommendation from the Depa...should receive below-inflation pay rises//. In its...Review Body, published today, the government argue... of 1.5%. In its own evidence to the Review Body,...
...e has claimed four lives in West Bengal and affect...sra said Thursday//. "There are four deaths so far...ra. City Mayor Bikash Bhattacharya had said earli...e in Kolkata were affected by dengue with one deat...
...ise in the number of chemotherapy patients has inc... people are requested to donate platelets.// Acco...he Irish Cancer Society (ICS), in the last 5 years...d for blood components due to the growing number o...
...a has more than 16% of its population which is est...e ravages of the deadly scourge AIDS.// It is how...has made considerable progress in keeping the HIV ...to the notice of the US government. In appreciatio...
Other Medicine News:Health News:Chemotherapy increases the demand for blood components 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: